CTOs on the Move

NeuBase Therapeutics

www.neubasetherapeutics.com

 
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Anthony Rossomando
 Chief Technology Officer Profile

Similar Companies

Brogan Pharmaceuticals

Brogan Pharmaceuticals is a Crown Point, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune-Onc Therapeutics

Immune-Onc Therapeutics, Inc. is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients.

Pharma Logistics

Pharma Logistics is a Mundelein, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CRC Consulting

CRC Consulting is a Roslindale, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bio-Solutions Manufacturing

Bio-Solutions Manufacturing Inc. is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.